North America Organoids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. North America Organoids Market – Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Demand for Tumor Modeling and Biobanking

4.1.2 Surging Adoption of Personalized Drugs

4.2 Market Restraints

4.2.1 Dearth of Skilled Professionals

4.3 Market Opportunities

4.3.1 Focus on Drug Discovery Activities

4.4 Future Trends

4.4.1 Combination of Organoids and Organ-on-a-Chip

4.5 Impact of Drivers and Restraints:

5. Organoids Market – North America Analysis

5.1 North America Organoids Market Revenue (US$ Million), 2021–2031

5.2 North America Organoids Market Forecast Analysis

6. North America Organoids Market Analysis – by Type

6.1 Intestine

6.1.1 Overview

6.1.2 Intestine: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.2 Liver

6.2.1 Overview

6.2.2 Liver: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.3 Stomach

6.3.1 Overview

6.3.2 Stomach: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.4 Pancreas

6.4.1 Overview

6.4.2 Pancreas: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.5 Lung

6.5.1 Overview

6.5.2 Lung: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.6 Brain

6.6.1 Overview

6.6.2 Brain: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.7 Kidney

6.7.1 Overview

6.7.2 Kidney: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.8 Others

6.8.1 Overview

6.8.2 Others: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7. North America Organoids Market Analysis – by Application

7.1 Developmental Biology Disease

7.1.1 Overview

7.1.2 Developmental Biology Disease: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2 Pathology of Infectious Disease

7.2.1 Overview

7.2.2 Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.3 Regenerative Medicine

7.3.1 Overview

7.3.2 Regenerative Medicine: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.4 Drug Toxicity and Efficacy Testing

7.4.1 Overview

7.4.2 Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.5 Drug Discovery and Personalized Medicine

7.5.1 Overview

7.5.2 Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

8. North America Organoids Market Analysis – by Source

8.1 Pluripotent Stem Cells

8.1.1 Overview

8.1.2 Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2 Organ-Specific Adult Stem Cell

8.2.1 Overview

8.2.2 Organ-Specific Adult Stem Cell: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9. North America Organoids Market Analysis – by Offering

9.1 Instruments

9.1.1 Overview

9.1.2 Instruments: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2 Consumables

9.2.1 Overview

9.2.2 Consumables: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3 Services

9.3.1 Overview

9.3.2 Services: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10. North America Organoids Market Analysis – by Method

10.1 Micropatterned Plates

10.1.1 Overview

10.1.2 Micropatterned Plates: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.2 Ultralow Attachment Plates

10.2.1 Overview

10.2.2 Ultralow Attachment Plates: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3 Hanging Drop

10.3.1 Overview

10.3.2 Hanging Drop: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4 Microdroplet or Emulsion

10.4.1 Overview

10.4.2 Microdroplet or Emulsion: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11. North America Organoids Market – Country Analysis

11.1 North America

11.1.1 North America Organoids Market – Revenue and Forecast Analysis – by Country

11.1.1.1 North America Organoids Market – Revenue and Forecast Analysis – by Country

11.1.1.2 United States: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.2.1 United States: North America Organoids Market Share – by Type

11.1.1.2.2 United States: North America Organoids Market Share – by Application

11.1.1.2.3 United States: North America Organoids Market Share – by Source

11.1.1.2.4 United States: North America Organoids Market Share – by Offering

11.1.1.2.5 United States: North America Organoids Market Share – by Instruments

11.1.1.2.6 United States: North America Organoids Market Share – by Consumables

11.1.1.2.7 United States: North America Organoids Market Share – by Method

11.1.1.3 Canada: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.3.1 Canada: North America Organoids Market Share – by Type

11.1.1.3.2 Canada: North America Organoids Market Share – by Application

11.1.1.3.3 Canada: North America Organoids Market Share – by Source

11.1.1.3.4 Canada: North America Organoids Market Share – by Offering

11.1.1.3.5 Canada: North America Organoids Market Share – by Instruments

11.1.1.3.6 Canada: North America Organoids Market Share – by Consumables

11.1.1.3.7 Canada: North America Organoids Market Share – by Method

11.1.1.4 Mexico: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.4.1 Mexico: North America Organoids Market Share – by Type

11.1.1.4.2 Mexico: North America Organoids Market Share – by Application

11.1.1.4.3 Mexico: North America Organoids Market Share – by Source

11.1.1.4.4 Mexico: North America Organoids Market Share – by Offering

11.1.1.4.5 Mexico: North America Organoids Market Share – by Instruments

11.1.1.4.6 Mexico: North America Organoids Market Share – by Consumables

11.1.1.4.7 Mexico: North America Organoids Market Share – by Method

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in Organoids Market

12.3 Organic Growth Strategies

12.3.1 Overview

12.4 Inorganic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 STEMCELL Technologies Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Molecular Devices, LLC.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Hubrecht Organoid Technology

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Definigen

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Organoid Therapeutics

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Thermo Fisher Scientific Inc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Corning Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Merck KGaA

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 InSphero

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 ACRO Biosystems.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Bio-Techne Corp

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 SUN bioscience SA

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 ORGANOID SCIENCES Co., Ltd.

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 Crown Bioscience Inc

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Sartorius AG

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

13.16 3D Biotek LLC

13.16.1 Key Facts

13.16.2 Business Description

13.16.3 Products and Services

13.16.4 Financial Overview

13.16.5 SWOT Analysis

13.16.6 Key Developments

13.17 Prellis Biologics Inc.

13.17.1 Key Facts

13.17.2 Business Description

13.17.3 Products and Services

13.17.4 Financial Overview

13.17.5 SWOT Analysis

13.17.6 Key Developments

13.18 3Dnamics Inc.

13.18.1 Key Facts

13.18.2 Business Description

13.18.3 Products and Services

13.18.4 Financial Overview

13.18.5 SWOT Analysis

13.18.6 Key Developments

13.19 Cellesce Ltd

13.19.1 Key Facts

13.19.2 Business Description

13.19.3 Products and Services

13.19.4 Financial Overview

13.19.5 SWOT Analysis

13.19.6 Key Developments

14. Appendix

14.1 About The Insight Partners

List of Tables

Table 1. North America Organoids Market Segmentation

Table 2. North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3. North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type

Table 4. North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application

Table 5. North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Source

Table 6. North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Offering

Table 7. North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Method

Table 8. North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 9. United States: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 10. United States: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 11. United States: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 12. United States: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 13. United States: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 14. United States: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 15. United States: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 16. Canada: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 17. Canada: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 18. Canada: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 19. Canada: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 20. Canada: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 21. Canada: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 22. Canada: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 23. Mexico: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 24. Mexico: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 25. Mexico: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 26. Mexico: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 27. Mexico: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 28. Mexico: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 29. Mexico: North America Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 30. Recent Organic Growth Strategies in Organoids Market

Table 31. Recent Inorganic Growth Strategies in the Organoids Market

List of Figures

Figure 1. North America Organoids Market Segmentation – Country

Figure 2. North America Organoids Market – Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Organoids Market Revenue (US$ Million), 2021–2031

Figure 5. North America Organoids Market Share (%) – by Type (2023 and 2031)

Figure 6. Intestine: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 7. Liver: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8. Stomach: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9. Pancreas: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10. Lung: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11. Brain: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12. Kidney: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13. Others: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14. North America Organoids Market Share (%) – by Application (2023 and 2031)

Figure 15. Developmental Biology Disease: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16. Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17. Regenerative Medicine: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18. Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19. Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20. Others: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 21. North America Organoids Market Share (%) – by Source (2023 and 2031)

Figure 22. Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 23. Organ-Specific Adult Stem Cell: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 24. North America Organoids Market Share (%) – by Offering (2023 and 2031)

Figure 25. Instruments: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 26. Consumables: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 27. Services: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 28. North America Organoids Market Share (%) – by Method (2023 and 2031)

Figure 29. Micropatterned Plates: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 30. Ultralow Attachment Plates: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 31. Hanging Drop: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 32. Microdroplet or Emulsion: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 33. Others: North America Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 34. North America Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 35. United States: North America Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 36. Canada: North America Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 37. Mexico: North America Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 38. Growth Strategies in Organoids Market